Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × netrin-1 inhibitor NP137 × 90 days × Clear all

Phase

Status

Suspended 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 25 Magnetic Resonance Spectroscopy 16 Biopsy 11 Cyclophosphamide 9 Vincristine 6 Doxorubicin 6 pembrolizumab 4 fludarabine 4 durvalumab 4 Prednisone 4 Nivolumab 4 Etoposide 4 Cisplatin 4 prednylidene 3 deltacortene 3 atezolizumab 3 Surveys and Questionnaires 3 Rituximab 3 Radiation 3 Lenalidomide 3 Ipilimumab 3 Dexamethasone 3 Carboplatin 3 venetoclax 2 trifluridine tipiracil drug combination 2 trastuzumab deruxtecan 2 tazemetostat 2 decitabine and cedazuridine drug combination 2 X-Rays 2 Temozolomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05546879 2026-02-10

Liver-NET1

University Hospital, Grenoble

Phase 1 Suspended

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡